Michael A Galella, Age 4954 Chipper Dr, Kendall Park, NJ 08824

Michael Galella Phones & Addresses

54 Chipper Dr, Kendall Park, NJ 08824 (732) 821-8730

54B Chipper Dr, Kendall Park, NJ 08824

49 Appletree Ln, Old Bridge, NJ 08857 (732) 679-3684

Bryn Mawr, PA

Belle Mead, NJ

Hillsborough, NJ

Bloomsburg, PA

State College, PA

Trappe, PA

Show more

Mentions for Michael A Galella

Michael Galella resumes & CV records

Resumes

Michael Galella Photo 16

Director, Vertex Center Of Excellence

Location:
54 Chipper Dr, Kendall Park, NJ 08824
Industry:
Computer Software
Work:
Vertex Inc.
Director, Vertex Center of Excellence
Sungard 1998 - 2001
Business Analyst
Systems and Computer Technology 1996 - 2001
Business Analyst
Thomson Mckinnon Securities 1986 - 1991
Supervisor
Education:
Fordham University 1982 - 1986
Bachelors, Bachelor of Science
Skills:
Business Analysis, Requirements Analysis, Erp, Sap, Enterprise Software, Business Process, Business Intelligence, Sdlc, Process Improvement, Integration, Business Process Improvement, Software Project Management, Agile Methodologies, Requirements Gathering, Crm, Software Development, Project Management, Software Documentation, Program Management, Saas, Sql, Microsoft Sql Server, Oracle, Enterprise Architecture, Databases, It Strategy, Data Warehousing, Software Implementation, Cloud Computing, Visio, Agile Project Management, Solution Architecture, Oracle E Business Suite, Software Development Life Cycle, Enterprise Resource Planning
Languages:
English
Michael Galella Photo 17

Lab Manager

Location:
Kendall Park, NJ
Industry:
Pharmaceuticals
Work:
Bristol-Myers Squibb
Lab Manager
Dupont Feb 1, 1998 - Jun 1, 1998
Contractor
Education:
Bloomsburg University of Pennsylvania 1994 - 1997
Bachelors, Bachelor of Science, Chemistry
Skills:
Crystallization, X Ray Crystallography, Hplc, Analytical Chemistry, Chromatography, Drug Discovery, Organic Chemistry, Lc Ms, Pharmaceutical Industry, Medicinal Chemistry, Technology Transfer, Organic Synthesis, Chemistry, Uv/Vis, Nmr, Small Molecule Solid State Analysis, Differential Scanning Calorimetry, Ir, Drug Design, Mass Spectrometry, Protein Chemistry, Crystallography, Powder X Ray Diffraction
Michael Galella Photo 18

Principal Owner

Work:
Ledacon
Principal Owner
Michael Galella Photo 19

Michael Galella

Location:
United States

Publications & IP owners

Us Patents

Polymorphs Of An Epothilone Analog

US Patent:
6982276, Jan 3, 2006
Filed:
Feb 6, 2004
Appl. No.:
10/773819
Inventors:
John D. DiMarco - East Brunswick NJ, US
Jack Z. Gougoutas - Princeton NJ, US
Imre M. Vitez - Whitehouse Station NJ, US
Martha Davidovich - East Brunswick NJ, US
Michael A. Galella - Old Bridge NJ, US
Timothy M. Malloy - Yardley PA, US
Zhenrong Guo - East Brunswick NJ, US
Denis Favreau - Saint-Hubert, CA
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 493/04
A61K 31/42
US Classification:
514365, 540456, 540462
Abstract:
There are provided in accordance with the present invention two crystalline polymorphs, designated Form A and Form B, respectively, as well as mixtures thereof, of an epothilone analog represented by the formula Also provided are methods of forming the novel polymorphs, therapeutic methods utilizing them and pharmaceutical dosage forms containing them.

Polymorphs Of An Epothilone Analog

US Patent:
7153879, Dec 26, 2006
Filed:
Nov 10, 2005
Appl. No.:
11/271456
Inventors:
John D. DiMarco - East Brunswick NJ, US
Jack Z. Gougoutas - Princeton NJ, US
Imre M. Vitez - Whitehouse Station NJ, US
Martha Davidovich - East Brunswick NJ, US
Michael A. Galella - Old Bridge NJ, US
Timothy M. Malloy - Yardley PA, US
Zhenrong Guo - East Brunswick NJ, US
Denis Favreau - Saint-Hubert, CA
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 493/04
A61K 31/42
A61P 35/00
US Classification:
514365, 540456, 540462
Abstract:
There are provided in accordance with the present invention two crystalline polymorphs, designated Form A and Form B, respectively, as well as mixtures thereof, of an epothilone analog represented by the formula.

Process For Preparing 2-Aminothiazole-5-Aromatic Carboxamides As Kinase Inhibitors

US Patent:
7491725, Feb 17, 2009
Filed:
Jul 29, 2005
Appl. No.:
11/192867
Inventors:
Jean Lajeunesse - Candiac, CA
John D. DiMarco - East Brunswick NJ, US
Michael Galella - Kendall Park NJ, US
Ramakrishnan Chidambaram - Pennington NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/506
C07D 403/04
US Classification:
51425219, 544295
Abstract:
The invention relates to processes for preparing compounds having the formula,.

Triazolopyridine 11-Beta Hydroxysteroid Dehydrogenase Type I Inhibitors

US Patent:
8119658, Feb 21, 2012
Filed:
Sep 9, 2008
Appl. No.:
12/206801
Inventors:
Jun Li - Princeton NJ, US
Jeffrey A. Robl - Newtown PA, US
James J. Li - Pennington NJ, US
Lawrence J. Kennedy - Titusville NJ, US
Haixia Wang - Princeton NJ, US
Jie Jack Li - Killingworth CT, US
Xinhua Qian - Flemington NJ, US
Rajendra P. Deshpande - Hillsborough NJ, US
Laxma R. Kolla - Princeton Junction NJ, US
Reginald O. Cann - Princeton Junction NJ, US
Chenkou Wei - Princeton Junction NJ, US
Michael Galella - Kendall Park NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/437
C07D 471/04
A61P 3/04
A61P 3/10
A61P 9/12
A61P 3/00
US Classification:
514303, 546119
Abstract:
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I:.

Process For Preparing 2-Aminothiazole-5-Aromatic Carboxamides As Kinase Inhibitors

US Patent:
8242270, Aug 14, 2012
Filed:
Dec 23, 2008
Appl. No.:
12/342141
Inventors:
Jean Lajeunesse - Candiac, CA
John D. DiMarco - East Brunswick NJ, US
Michael Galella - Kendall Park NJ, US
Ramakrishnan Chidambaram - Santa Clara CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 403/04
US Classification:
544295
Abstract:
The invention relates to processes for preparing compounds having the formula,.

Triazolopyridine 11-Beta Hydroxysteroid Dehydrogenase Type I Inhibitors

US Patent:
8541444, Sep 24, 2013
Filed:
Aug 3, 2011
Appl. No.:
13/197273
Inventors:
Jun Li - Princeton NJ, US
Jeffrey A. Robl - Newtown PA, US
James J. Li - Pennington NJ, US
Lawrence J. Kennedy - Titusville NJ, US
Haixia Wang - Princeton NJ, US
Jie Jack Li - Killingworth CT, US
Chenkou Wei - Princeton Junction NJ, US
Michael Galella - Kendall Park NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 471/02
C07D 491/02
C07D 498/02
A61K 31/44
US Classification:
514303, 546119
Abstract:
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I:.

Polymorphs Of An Epothilone Analog

US Patent:
2002018, Dec 12, 2002
Filed:
Aug 9, 2001
Appl. No.:
09/925112
Inventors:
John DiMarco - East Brunswick NJ, US
Jack Gougoutas - Princeton NJ, US
Imre Vitez - Whitehouse Station NJ, US
Martha Davidovich - East Brunswick NJ, US
Michael Galella - Old Bridge NJ, US
Timothy Malloy - Yardley PA, US
Zhenrong Guo - East Brunswick NJ, US
Denis Favreau - Saint-Hubert, CA
International Classification:
C07D491/02
A61K031/427
US Classification:
514/365000, 540/462000
Abstract:
There are provided in accordance with the present invention two crystalline polymorphs, designated Form A and Form B, respectively, as well as mixtures thereof, of an epothilone analog represented by the formula Also provided are methods of forming the novel polymorphs, therapeutic methods utilizing them and pharmaceutical dosage forms containing them.

Process For Preparing 2-Aminothiazole-5-Aromatic Carboxamides As Kinase Inhibitors

US Patent:
2005021, Sep 29, 2005
Filed:
Feb 4, 2005
Appl. No.:
11/051208
Inventors:
Roberto Droghini - Candiac, CA
Jean Lajeunesse - Candiac, CA
John Dimarco - East Brunswick NJ, US
Michael Galella - Kendall Park NJ, US
Ramakrishnan Chidambaram - Pennington NJ, US
International Classification:
A61K031/426
C07D417/02
US Classification:
548190000
Abstract:
The invention relates to processes for preparing compounds having the formula, and crystalline forms thereof, wherein Ar is aryl or heteroaryl, L is an optional alkylene linker, and R, R, R, and R, are as defined in the specification herein, which compounds are useful as kinase inhibitors, in particular, inhibitors of protein tyrosine kinase and p38 kinase.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.